Literature DB >> 21341275

Intrinsic cell memory reinforces myogenic commitment of pericyte-derived iPSCs.

Mattia Quattrocelli1, Giacomo Palazzolo, Giuseppe Floris, Patrick Schöffski, Luigi Anastasia, Aldo Orlacchio, Thierry Vandendriessche, Marinee K L Chuah, Giulio Cossu, Catherine Verfaillie, Maurilio Sampaolesi.   

Abstract

Mesoangioblasts (MABs) are a subset of muscle-derived pericytes able to restore dystrophic phenotype in mice and dogs. However, their lifespan is limited and they undergo senescence after 25-30 population doublings. Recently, induced pluripotent stem cells (iPSCs) generated from reprogrammed fibroblasts have been demonstrated to have in vitro and in vivo myogenic potential when sorted for the SM/C-2.6 antigen. Furthermore, chimeric mice from mdx-iPSCs (DYS-HAC) cells showed tissue-specific expression of dystrophin. Nevertheless, myogenic differentiation protocols and the potential of iPSCs generated from different cell sources still present unanswered questions. Here we show that iPSCs generated from prospectively sorted MABs (MAB-iPSCs) are pluripotent as fibroblast-derived iPSCs (f-iPSCs). However, both teratoma formation and genetic cell manipulation assays identify a durable epigenetic memory in MAB-iPSCs, resulting in stronger myogenic commitment. Striated muscle tissue accounts for up to 70% of MAB-iPSC teratomas. Moreover, transfection with Pax3 and Pax7 induces a more robust myogenic differentiation in MAB-iPSCs than in f-iPSCs. A larger amount of CD56(+) progenitors can be sorted from the MAB-iPSCs differentiating pool and, after transplantation into αsg-KO mice, can efficiently participate to skeletal muscle regeneration and restore αsg expression. Our data strongly suggest that iPSCs are a heterogeneous population and, when generated from myogenic adult stem cells, they exhibit a stronger commitment, paving the way for creating custom-made cell protocols for muscular dystrophies.
Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21341275     DOI: 10.1002/path.2845

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  42 in total

1.  Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells.

Authors:  Tea Soon Park; Ludovic Zimmerlin; Elias T Zambidis
Journal:  Cytometry A       Date:  2012-06-26       Impact factor: 4.355

Review 2.  The hematopoietic system in the context of regenerative medicine.

Authors:  Christopher D Porada; Anthony J Atala; Graça Almeida-Porada
Journal:  Methods       Date:  2015-08-28       Impact factor: 3.608

3.  Comparison of potentials of stem cells isolated from tendon and bone marrow for musculoskeletal tissue engineering.

Authors:  Qi Tan; Pauline Po Yee Lui; Yun Feng Rui; Yin Mei Wong
Journal:  Tissue Eng Part A       Date:  2011-12-13       Impact factor: 3.845

Review 4.  Selecting the optimal cell for kidney regeneration: fetal, adult or reprogrammed stem cells.

Authors:  Orit Harari-Steinberg; Oren Pleniceanu; Benjamin Dekel
Journal:  Organogenesis       Date:  2011-04-01       Impact factor: 2.500

5.  Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells.

Authors:  Sergio Ruiz; Dinh Diep; Athurva Gore; Athanasia D Panopoulos; Nuria Montserrat; Nongluk Plongthongkum; Sachin Kumar; Ho-Lim Fung; Alessandra Giorgetti; Josipa Bilic; Erika M Batchelder; Holm Zaehres; Natalia G Kan; Hans Robert Schöler; Mark Mercola; Kun Zhang; Juan Carlos Izpisua Belmonte
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-18       Impact factor: 11.205

6.  Converting pathological cells to therapeutic ones: an odyssey through pluripotency.

Authors:  Jean-Thomas Vilquin
Journal:  Mol Ther       Date:  2012-11       Impact factor: 11.454

7.  Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro.

Authors:  Jérome Chal; Ziad Al Tanoury; Marie Hestin; Bénédicte Gobert; Suvi Aivio; Aurore Hick; Thomas Cherrier; Alexander P Nesmith; Kevin K Parker; Olivier Pourquié
Journal:  Nat Protoc       Date:  2016-09-01       Impact factor: 13.491

8.  Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle.

Authors:  Mattia Quattrocelli; Melissa Swinnen; Giorgia Giacomazzi; Jordi Camps; Ines Barthélemy; Gabriele Ceccarelli; Ellen Caluwé; Hanne Grosemans; Lieven Thorrez; Gloria Pelizzo; Manja Muijtjens; Catherine M Verfaillie; Stephane Blot; Stefan Janssens; Maurilio Sampaolesi
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

9.  Engraftment of ES-Derived Myogenic Progenitors in a Severe Mouse Model of Muscular Dystrophy.

Authors:  Antonio Filareto; Radbod Darabi; Rita C R Perlingeiro
Journal:  J Stem Cell Res Ther       Date:  2012-01-06

Review 10.  Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks.

Authors:  Fabrizio Rinaldi; Rita C R Perlingeiro
Journal:  Transl Res       Date:  2013-11-14       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.